Indicators for Monitoring National Drug Policies
(1999; 250 pages) [French] Voir le document au format PDF
Table des matières
Afficher le documentACKNOWLEDGEMENTS
Ouvrir ce répertoire et afficher son contenuCHAPTER I: Introduction
Ouvrir ce répertoire et afficher son contenuCHAPTER II: Development of the manual
Ouvrir ce répertoire et afficher son contenuCHAPTER III: Model lists of indicators
Fermer ce répertoireCHAPTER IV: Methodology for indicator calculation
Afficher le documentOrganizing the data collection
Afficher le documentCollecting data
Afficher le documentAnalysis and reporting
Afficher le documentConducting surveys
Afficher le documentCalculating the value of a basket of drugs
Ouvrir ce répertoire et afficher son contenuCHAPTER V: Detailed presentation of indicators
Ouvrir ce répertoire et afficher son contenuANNEX 1: Data collection forms
Afficher le documentANNEX 2: Glossary
Afficher le documentANNEX 3: Table of random numbers
Afficher le documentBACK COVER
 

CHAPTER IV: Methodology for indicator calculation

The objective of this chapter is to provide information on the various steps which should be taken when applying indicators, as part of an indicator exercise (assessment of the pharmaceutical situation at a moment in time) or within a continuous monitoring system.

When assessing or monitoring a national drug policy (NDP), identifying appropriate indicators and data sources, determining how to collect the data, organizing the collection and analysing the results should be carefully planned. The choice of the indicators and the quality of the information collected will affect the validity of the results and the appropriateness of the changes proposed. The main steps for ensuring that the results of the monitoring are accurate and reliable are reviewed below.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 24 avril 2012